[Sarcoidosis after interferon-alpha treatment in hepatitis C].
Krehmeier
H
H
Medizinische Klinik I Klinikum Lippe Detmold Röntgenstrasse 18 32756 Detmold.
Egberts
E H
EH
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects*; D001992:Bronchoalveolar Lavage Fluid; D004417:Dyspnea / Q000209:etiology; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D013902:Radiography, Thoracic; D017565:Sarcoidosis, Pulmonary / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D011239:Prednisolone